BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30588482)

  • 1. Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy.
    Mohassel P; Landon-Cardinal O; Foley AR; Donkervoort S; Pak KS; Wahl C; Shebert RT; Harper A; Fequiere P; Meriggioli M; Toro C; Drachman D; Allenbach Y; Benveniste O; Béhin A; Eymard B; Lafôret P; Stojkovic T; Mammen AL; Bönnemann CG
    Neurol Neuroimmunol Neuroinflamm; 2019 Jan; 6(1):e523. PubMed ID: 30588482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slowly Progressive Limb-Girdle Weakness and HyperCKemia - Limb Girdle Muscular Dystrophy or Anti-3-Hydroxy-3-Methylglutaryl-CoA-Reductase-Myopathy?
    Hiebeler M; Franke R; Ingenerf M; Krause S; Mohassel P; Pak K; Mammen A; Schoser B; Bönnemann CG; Walter MC
    J Neuromuscul Dis; 2022; 9(5):607-614. PubMed ID: 35754285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HMGCR myopathy mimicking limb-girdle muscular dystrophy and the response to Rituximab.
    Idiculla PS; Govindarajan R
    Clin Neurol Neurosurg; 2020 Jul; 194():105871. PubMed ID: 32447205
    [No Abstract]   [Full Text] [Related]  

  • 4. [Childhood-onset anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myopathy needs to be distinguished from muscular dystrophy: A case study].
    Hama Y; Mori-Yoshimura M; Komaki H; Suzuki S; Kohsaka H; Nishino I; Takahashi Y
    Rinsho Shinkeigaku; 2017 Oct; 57(10):567-572. PubMed ID: 28966227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HMGCR myopathy: barriers to prompt recognition.
    Barp A; Merve A; Shah S; Desikan M; Hanna MG; Bugiardini E
    Pract Neurol; 2023 Jun; 23(3):239-242. PubMed ID: 36564213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HMGCR Myopathy.
    Mohassel P; Mammen AL
    J Neuromuscul Dis; 2018; 5(1):11-20. PubMed ID: 29480216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bi-allelic variants in HMGCR cause an autosomal-recessive progressive limb-girdle muscular dystrophy.
    Morales-Rosado JA; Schwab TL; Macklin-Mantia SK; Foley AR; Pinto E Vairo F; Pehlivan D; Donkervoort S; Rosenfeld JA; Boyum GE; Hu Y; Cong ATQ; Lotze TE; Mohila CA; Saade D; Bharucha-Goebel D; Chao KR; Grunseich C; Bruels CC; Littel HR; Estrella EA; Pais L; Kang PB; Zimmermann MT; Lupski JR; Lee B; Schellenberg MJ; Clark KJ; Wierenga KJ; Bönnemann CG; Klee EW
    Am J Hum Genet; 2023 Jun; 110(6):989-997. PubMed ID: 37167966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
    Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL
    Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.
    Drouot L; Allenbach Y; Jouen F; Charuel JL; Martinet J; Meyer A; Hinschberger O; Bader-Meunier B; Kone-Paut I; Campana-Salort E; Eymard B; Tournadre A; Musset L; Sibilia J; Marie I; Benveniste O; Boyer O;
    Arthritis Res Ther; 2014 Feb; 16(1):R39. PubMed ID: 24484965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.
    Allenbach Y; Drouot L; Rigolet A; Charuel JL; Jouen F; Romero NB; Maisonobe T; Dubourg O; Behin A; Laforet P; Stojkovic T; Eymard B; Costedoat-Chalumeau N; Campana-Salort E; Tournadre A; Musset L; Bader-Meunier B; Kone-Paut I; Sibilia J; Servais L; Fain O; Larroche C; Diot E; Terrier B; De Paz R; Dossier A; Menard D; Morati C; Roux M; Ferrer X; Martinet J; Besnard S; Bellance R; Cacoub P; Arnaud L; Grosbois B; Herson S; Boyer O; Benveniste O;
    Medicine (Baltimore); 2014 May; 93(3):150-157. PubMed ID: 24797170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
    Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A
    Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
    Liang WC; Uruha A; Suzuki S; Murakami N; Takeshita E; Chen WZ; Jong YJ; Endo Y; Komaki H; Fujii T; Kawano Y; Mori-Yoshimura M; Oya Y; Xi J; Zhu W; Zhao C; Watanabe Y; Ikemoto K; Nishikawa A; Hamanaka K; Mitsuhashi S; Suzuki N; Nishino I
    Rheumatology (Oxford); 2017 Feb; 56(2):287-293. PubMed ID: 27818386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned.
    Ghaoui R; Cooper ST; Lek M; Jones K; Corbett A; Reddel SW; Needham M; Liang C; Waddell LB; Nicholson G; O'Grady G; Kaur S; Ong R; Davis M; Sue CM; Laing NG; North KN; MacArthur DG; Clarke NF
    JAMA Neurol; 2015 Dec; 72(12):1424-32. PubMed ID: 26436962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: key points to prevent misdiagnosis.
    Marago I; Roberts M; Roncaroli F; DuPlessis D; Sewry C; Nagaraju S; Limbada F; Marini-Bettolo C; Hudson J; Banerjee S; Newton L; Bukhari M; Chinoy H; Lilleker JB
    Rheumatology (Oxford); 2022 Apr; 61(4):1645-1650. PubMed ID: 34264321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive paraneoplastic necrotizing myopathy associated with advanced gastric cancer that responded to intravenous immunoglobulin therapy].
    Yamaguchi T; Matsunaga A; Ikawa M; Shirafuji N; Nishino I; Hamano T
    Rinsho Shinkeigaku; 2017 Mar; 57(3):118-123. PubMed ID: 28228619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
    Williams B; Horn MP; Banz Y; Feldmeyer L; Villiger PM
    J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies.
    Preisler N; Lukacs Z; Vinge L; Madsen KL; Husu E; Hansen RS; Duno M; Andersen H; Laub M; Vissing J
    Mol Genet Metab; 2013 Nov; 110(3):287-9. PubMed ID: 24011652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort.
    Waters MJ; Limaye V
    Clin Rheumatol; 2018 Feb; 37(2):543-547. PubMed ID: 28905130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.